Interferon-γ/CCR5 expression in invariant natural killer T cells and CCL5 expression in capillary veins of dermal papillae correlate with development of psoriasis vulgaris

British Journal of Dermatology

Volumn 170, Issue 5, 2014, Pages 1048-1055

  Kono, F ^a   Honda, T ^a   Aini, W ^a   Manabe, T ^b   Haga, H ^a   Tsuruyama, T ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b SHIGA MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; RANTES; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR V ALPHA 24 CHAIN; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; EPIDERMIS HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIFORM HYPERPLASIA; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; SKIN BIOPSY; SKIN CAPILLARY; SKIN PAPILLA; VERY ELDERLY; YOUNG ADULT; CAPILLARY; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; PSORIASIS;

ADULT; AGED; CAPILLARIES; CASE-CONTROL STUDIES; CHEMOKINE CCL5; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84901020049     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12812     Document Type: Article

References (30)

1. Eyerich S, Onken AT, Weidinger S, et al,. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011; 365: 231-8.
2. Eyerich S, Eyerich K, Pennino D, et al,. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119: 3573-85.
3. Nograles KE, Zaba LC, Shemer A, et al,. IL-22-producing 'T22' T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123: 1244-452.e2
4. Cameron AL, Kirby B, Fei W, Griffiths CE,. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 2002; 294: 363-9.
5. Zhao YM, Fishelevich R, Petrali JP, et al,. Activation of keratinocyte protein kinase C zeta in psoriasis plaques. J Invest Dermatol 2008; 128: 2190-7.
6. Taniguchi M, Harada M, Kojo S, et al,. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483-513.
7. Exley M, Porcelli S, Furman M, et al,. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor α chains. J Exp Med 1998; 188: 867-76.
8. Lee PT, Benlagha K, Teyton L, Bendelac A,. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 2002; 195: 637-41.
9. Terabe M, Matsui S, Noben-Trauth N, et al,. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515-20.
10. Fuss IJ, Heller F, Boirivant M, et al,. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 2004; 113: 1490-7.
11. Seino KI, Fukao K, Muramoto K, et al,. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001; 98: 2577-81.
12. Tsuruyama T, Fujimoto Y, Yonekawa Y, et al,. Invariant natural killer T cells infiltrate intestinal allografts undergoing acute cellular rejection. Transpl Int 2012; 25: 537-44.
13. Ito K, Karasawa M, Kawano T,. Involvement of decidual Vα14 NKT cells in abortion. Proc Natl Acad Sci USA 2000; 97: 740-4.
14. Beaudoin L, Laloux V, Novak J, et al,. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002; 17: 725-36.
15. Araujo LM, Lefort J, Nahori MA, et al,. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. Eur J Immunol 2004; 34: 327-35.
16. Gyimesi E, Nagy G, Remenyik É, et al,. Altered peripheral invariant natural killer T cells in atopic dermatitis. J Clin Immunol 2011; 31: 864-72.
17. Simon D, Kozlowski E, Simon H,. Natural killer T cells expressing IFN-gamma and IL-4 in lesional skin of atopic eczema. Allergy 2009; 64: 1681-4.
18. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA,. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000; 24: 212-25.
19. Brennan PJ, Tatituri RV, Brigl M, et al,. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011; 12: 1202-11.
20. Aini W, Miyagawa-Hayashino A, Tsuruyama T, et al,. Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts. Transpl Int 2012; 25: 956-66.
21. Ishida Y, Kimura A, Kuninaka Y, et al,. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J Clin Invest 2012; 122: 711-21.
22. Schneider DF, Palmer JL, Tulley JM, et al,. Prevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signals. J Surg Res 2011; 171: 361-73.
23. Ottaviani C, Nasorri F, Bedini C, et al,. CD56brightCD16- NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36: 118-28.
24. Tachibana T, Onodera H, Tsuruyama T, et al,. Increased intratumor Vα24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 2005; 11: 7322-7.
25. Luci C, Gaudy-Marqueste C, Rouzaire P, et al,. Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis. Br J Dermatol 2012; 166: 789-96.
26. Ghoreschi K, Thomas P, Breit S, et al,. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-6.
27. de Groot M, Teunissen MB, Ortonne JP, et al,. Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor. Arch Dermatol Res 2007; 299: 305-13.
28. Zheng Y, Danilenko DM, Valdez P, et al,. Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-51.
29. Caruso R, Botti E, Sarra M, et al,. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 2009; 15: 1013-15.
30. Rachitskaya AV, Hansen AM, Horai R, et al,. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008; 180: 5167-71.